Repeated Cardiopulmonary Exercise Testing of ME/CFS Patients.
Hodges, Lynette · Methods in molecular biology (Clifton, N.J.) · 2025 · DOI
Quick Summary
This study explains how doctors use a special exercise test done twice (24 hours apart) to measure how ME/CFS affects the body's ability to exercise. The test shows that people with ME/CFS often cannot exercise as hard the second time, and their bodies don't use oxygen or produce power the way healthy people do. This helps prove that ME/CFS causes real, measurable changes in how the body functions.
Why It Matters
Repeated exercise testing provides objective, measurable evidence that ME/CFS causes real physiological dysfunction rather than deconditioning or psychological causes. This validation is crucial for patients seeking diagnosis and medical recognition, and helps researchers identify biological mechanisms underlying the disease's hallmark symptom of post-exertional malaise.
Observed Findings
Reduction in peak VO₂ between first and second exercise tests 24 hours apart
Decreased VO₂ at ventilatory threshold on repeated testing
Reduced power output at both peak exercise and ventilatory threshold on day 2
Post-exertional malaise documented in 95% of ME/CFS patients studied
Inferred Conclusions
Repeated CPET objectively demonstrates physiological impairment in ME/CFS that differs from healthy exercise responses
ME/CFS affects multiple physiological systems including oxygen utilization, cardiovascular response, and metabolic capacity
The 24-hour repeated testing protocol can reveal post-exertional malaise as a measurable, reproducible physiological phenomenon
Remaining Questions
What specific cellular or molecular mechanisms cause the observed reduction in exercise capacity between repeated tests?
Do different ME/CFS patient subgroups show varying patterns of response on repeated CPET?
How do repeated CPET results correlate with other biomarkers of ME/CFS pathophysiology (mitochondrial function, autonomic tone, inflammatory markers)?
What This Study Does Not Prove
This is a methods chapter describing testing procedures rather than a clinical trial; it does not establish new treatment efficacy or prove specific causes of ME/CFS pathophysiology. The study does not demonstrate whether observed exercise impairment results from mitochondrial dysfunction, autonomic dysfunction, metabolic abnormalities, or other mechanisms. It also does not establish prevalence rates or provide comparative effectiveness data against other diagnostic tests.